1. Home
  2. Clinical Topics
  3. Cardio-Pulmonary
  4. FDA approves first drug-eluting stent for treating PAD
Cardio-PulmonaryClinical TopicsDrugs and DevicesHealthcare & TechnologyNewsWeb Exclusives

FDA approves first drug-eluting stent for treating PAD

Share

On Nov. 15, the U.S. Food and Drug Administration (FDA) approved the Zilver PTX Drug-Eluting Peripheral Stent (Zilver PTX Stent), the first drug-eluting stent indicated to re-open the femoropopliteal artery when narrowed or blocked as a result of peripheral artery disease (PAD). Read more.

Leave a Reply

Your email address will not be published.

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts